Skip to main content
. Author manuscript; available in PMC: 2010 Aug 24.
Published in final edited form as: J Diet Suppl. 2010 Jun 1;7(2):159–178. doi: 10.3109/19390211.2010.482041

FIGURE 7.

FIGURE 7

ROI-quantitative measurement of percentage gadolinium-enhanced MRI areas in the control-fed group (25.1% ± 13.6% SD, n = 10) compared with the Protandim®-fed group (15.6% ± 6.2% SD, n = 15) at 6 months showed a mean 38% reduction in the Protandim group, but did not reach statistical significance (p = .07).